Actinogen Medical Ltd - Asset Resilience Ratio

Latest as of December 2024: 74.78%

Actinogen Medical Ltd (ACW) has an Asset Resilience Ratio of 74.78% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

AU$19.02 Million

≈ $13.45 Million USD Cash + Short-term Investments

Total Assets

AU$25.43 Million

≈ $17.99 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Actinogen Medical Ltd's Asset Resilience Ratio has changed over time. Check ACW PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Actinogen Medical Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Actinogen Medical Ltd market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$19.02 Million	74.78%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$19.02 Million	74.78%

Asset Resilience Insights

Very High Liquidity: Actinogen Medical Ltd maintains exceptional liquid asset reserves at 74.78% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Actinogen Medical Ltd Industry Peers by Asset Resilience Ratio

Compare Actinogen Medical Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	10.93%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	57.90%
TELIX Pharmaceuticals Ltd AU:TLX	Biotechnology	32.29%
Inner Mongolia Furui Med Sci SHE:300049	Biotechnology	2.34%
Bicara Therapeutics Inc. Common Stock NASDAQ:BCAX	Biotechnology	39.07%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%

Annual Asset Resilience Ratio for Actinogen Medical Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Actinogen Medical Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	33.86%	AU$7.22 Million ≈ $5.11 Million	AU$21.31 Million ≈ $15.08 Million	-13.35pp
2023-06-30	47.21%	AU$7.18 Million ≈ $5.08 Million	AU$15.21 Million ≈ $10.76 Million	-4.71pp
2022-06-30	51.92%	AU$12.10 Million ≈ $8.56 Million	AU$23.31 Million ≈ $16.49 Million	+13.28pp
2021-06-30	38.63%	AU$7.10 Million ≈ $5.02 Million	AU$18.38 Million ≈ $13.00 Million	+8.77pp
2020-06-30	29.87%	AU$3.56 Million ≈ $2.52 Million	AU$11.94 Million ≈ $8.45 Million	-17.21pp
2019-06-30	47.08%	AU$7.64 Million ≈ $5.40 Million	AU$16.22 Million ≈ $11.48 Million	-7.83pp
2018-06-30	54.90%	AU$9.90 Million ≈ $7.00 Million	AU$18.03 Million ≈ $12.75 Million	+15.83pp
2017-06-30	39.07%	AU$3.99 Million ≈ $2.82 Million	AU$10.21 Million ≈ $7.22 Million	+7.98pp
2016-06-30	31.09%	AU$4.03 Million ≈ $2.85 Million	AU$12.95 Million ≈ $9.16 Million	--

pp = percentage points

About Actinogen Medical Ltd

AU:ACW Australia Biotechnology

Market Cap

$96.71 Million

AU$136.67 Million AUD

Market Cap Rank

#19312 Global

#618 in Australia

Share Price

AU$0.04

Change (1 day)

+0.00%

52-Week Range

AU$0.02 - AU$0.07

All Time High

AU$0.18